[go: up one dir, main page]

HK1178455A - Methods, compositions, and kits for the treatment of matrix mineralization disorders - Google Patents

Methods, compositions, and kits for the treatment of matrix mineralization disorders Download PDF

Info

Publication number
HK1178455A
HK1178455A HK13105541.8A HK13105541A HK1178455A HK 1178455 A HK1178455 A HK 1178455A HK 13105541 A HK13105541 A HK 13105541A HK 1178455 A HK1178455 A HK 1178455A
Authority
HK
Hong Kong
Prior art keywords
kits
compositions
treatment
methods
matrix mineralization
Prior art date
Application number
HK13105541.8A
Other languages
Chinese (zh)
Inventor
菲利普．昆恩
彼埃尔．伦纳德
Original Assignee
亚力兄国际制药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 亚力兄国际制药有限公司 filed Critical 亚力兄国际制药有限公司
Publication of HK1178455A publication Critical patent/HK1178455A/en

Links

HK13105541.8A 2010-04-30 2011-04-29 Methods, compositions, and kits for the treatment of matrix mineralization disorders HK1178455A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/329,877 2010-04-30

Publications (1)

Publication Number Publication Date
HK1178455A true HK1178455A (en) 2013-09-13

Family

ID=

Similar Documents

Publication Publication Date Title
IL222695A0 (en) Methods, compositions, and kits for the treatment of matrix mineralization disorders
WO2011049960A9 (en) Compositions and methods for the treatment of sinonasal disorders
WO2012149472A9 (en) Methods, compositions, and kits for treating and preventing neurological conditions
WO2010062863A3 (en) Compositions containing satiogens and methods of use
WO2011140517A9 (en) Methods for treating diseases of the lung
ZA201203603B (en) Lyophilization methods, compositions, and kits
PT2563316T (en) Methods, articles and kits for allergic desensitization via the oral mucosa
WO2011129936A3 (en) Compositions and methods for the prevention and treatment of cancer
WO2012021287A9 (en) Methods for the treatment and prevention of metabolic disorders
WO2011112588A9 (en) Compositions and methods for treating inflammatory disorders
WO2012061413A3 (en) Isoflavonoid compositions and methods for the treatment of cancer
WO2011137427A9 (en) Compositions and methods for treating pulmonary conditions
EP3081097B8 (en) Composition for the treatment of infertility
WO2011088020A9 (en) Modified saponins for the treatment of fungal infections
WO2011156820A9 (en) Compositions, methods and uses for treatment of type 1 diabetes
WO2012078746A9 (en) Compositions and methods for mobilizing stem cells
WO2011084523A3 (en) Ulk1 compositions, inhibitors, screening and methods of use
HK1178455A (en) Methods, compositions, and kits for the treatment of matrix mineralization disorders
EP2544534A4 (en) Compositions, methods, and devices for the treatment of dysmenorrhea
HK1255654A (en) Compositions and methods for treating myelofibrosis
HK1172652A (en) Methods and compositions for the treatment of proliferative and pathogenic diseases
HK1192471A (en) Compositions, devices and methods of use thereof for the treatment of cancers
IL222623A (en) Compositions and kits for providing therapeutic treatment
AU2010902219A0 (en) Compositions and methods for treating neurodegenerative disorders
HK1186483A (en) Methods of treating fgf21-associated disorders